Epidiolex 100 mg/mL Oral Solution for Toothache
This trial will test whether CBD can help relieve dental pain. Subjects will be given either CBD or a placebo, and then monitored for pain and psychological effects for 3 hours.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is this medical experiment actively engaging those over seventy years of age?
"As outlined in the guidelines for this trial, only individuals aged between 18 and 75 are qualified to participate."
Might I qualify to be a participant in this experiment?
"In order to be accepted, potential volunteers must suffer from dental pain and fit within the 18-75 year old age bracket. The research team is looking for a total of 60 participants."
Is this research initiative still open to new participants?
"As per clinicaltrials.gov, this experiment is still accepting applicants. Initially announced on March 1st 2021 and edited lastly on March 31st 2022, the trial requires more participants to join in its endeavour."
What have been the findings of prior research into Epidiolex 100 mg/mL Oral Solution?
"Currently, 79 clinical trials for Epidiolex 100 mg/mL Oral Solution are occurring worldwide. Out of these trials, 16 have progressed to Phase 3 already. The majority of studies are based in Ribeirao Preto, Sao Paulo with a total number of 290 sites participating overall."
How many participants are enrolled in this research endeavor?
"Affirmative. Clinicaltrials.gov show that this trial is accepting applicants and was first published on March 1st 2021, with the most recent ammendments occuring at the end of March 2022. The project requires 60 volunteers from a single hospital site."